In the Media

The Economist reports on the growing popularity of ingestible sensors, including work at MIT where researchers are using the devices to “sense internal conditions and act on what they find.”  The MIT team “received $66m from ARPA-H, a federal grant system that pushes high-risk, transformative health-care technology, to develop ingestible devices for the oral delivery of mRNA treatments.”